Logo Logo
Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 7.

Journal article

Berger, Martin D.; Yamauchi, Shinichi; Cao, Shu; Hanna, Diana L.; Sunakawa, Yu; Schirripa, Marta; Matsusaka, Satoshi; Yang, Dongyun; Groshen, Susan; Zhang, Wu; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Lonardi, Sara; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Loupakis, Fotios; Stintzing, Sebastian; Lenz, Heinz-Josef (2017): Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials. In: European Journal of Cancer, Vol. 77: pp. 13-20

Okazaki, Satoshi; Stintzing, Sebastian; Sunakawa, Yu; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Matsusaka, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; West, Jordan D.; Gopez, Roel; Akihito, Tsuji; Ichikawa, Wataru; Heinemann, Volker; DePaolo, R. William; Lenz, Heinz-Josef (2017): Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer. In: International Journal of Cancer, Vol. 141, No. 6: pp. 1222-1230

Schirripa, Marta; Zhang, Wu; Heinemann, Volker; Cao, Shu; Okazaki, Satoshi; Yang, Dongyun; Loupakis, Fotios; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Gopez, Roel F.; West, Jordan D.; Hanna, Diana; Barzi, Afsaneh; Falcone, Alfredo; Stintzing, Sebastian; Lenz, Heinz-Josef (2017): Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial. In: International Journal of Cancer, Vol. 141, No. 2: pp. 383-392

Matsusaka, Satoshi; Hanna, Diana L.; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Okazaki, Satoshi; Berger, Martin D.; Miyamato, Yuji; Parekh, Anish; Stintzing, Sebastian; Loupakis, Fotios; Lenz, Heinz-Josef (2016): Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. In: Clinical Cancer Research, Vol. 22, No. 13: pp. 3218-3226

Okazaki, Satoshi; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Berger, Martin D.; Parekh, Anish; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; DePaolo, R. William; Lenz, Heinz-Josef (2016): Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab. In: Molecular Cancer therapeutics, Vol. 15, No. 7: pp. 1740-1745

Okazaki, Satoshi; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Matsusaka, Satoshi; Berger, Martin D.; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Lenz, Heinz-Josef (2016): Association of TLR9 polymorphism with overall survival in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab enrolled in FIRE3. In: Journal of Clinical Oncology, Vol. 34, No. 4

Berger, Martin D.; Stintzing, Sebastian; Heinemann, Volker; Yang, Dongyun; Sunakawa, Yu; Ning, Yan; Matsusaka, Satoshi; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; West, Jordan David; Zhang, Wu; Petasis, Nicos; Lenz, Heinz-Josef (2016): Serum amyloid a (SAA-1) SNP rs12218 to predict outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial. In: Journal of Clinical Oncology, Vol. 34, No. 4

This list was generated on Wed May 22 04:55:53 2019 CEST.